Teutonic launches new herbal medicine ciprofloxacino

The German Laboratory/Pfizer expands its portfolio of antibiotics and released this month, the Teuciprox, a drug similar to the base of the ciprofloxacin hydrochloride. With approximately 70 new products each year and a total of 138 presentations released only in 2013, the company must maintain the pace of launches in 2014.
The Teuciprox is an antibacterial and is available in packages of 7 or 14 in the concentration of coated tablets 500 mg. the medicine acts in the treatment of infections by blocking the gyrase, bacterial enzyme that has role in metabolism and reproduction of this microorganism. In this way, the product eliminates the disease-causing germs.